Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Onconova Therapeutics Inc

CUSIP: 68232V901 | 3 institutional holders

Quarters

Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile